Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gold

Showing results (771-780 of 1,272) with videos related to

Pageof 128
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2023
The MoXFo initiative - study design: Considerations related to study design and methodology in exercise research for people with multiple sclerosisUlrik Dalgas, Morten Riemenschneider, Stefan M Gold, et al.
Nature Communications|May 8, 2020
Cryo-electron microscopy reveals two distinct type IV pili assembled by the same bacteriumAlexander Neuhaus, Muniyandi Selvaraj, Ralf Salzer, et al.
Neuropsychologia|July 11, 2015
Cortical contributions to impaired contour integration in schizophreniaSteven M Silverstein, Michael P Harms, Cameron S Carter, et al.
Journal of Neuroimmunology|October 12, 2016
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosisSven Briken, Sina Cathérine Rosenkranz, Oliver Keminer, et al.
The Journal of Nervous and Mental Disease|December 14, 2020
Predicting Attention-Shaping Response in People With SchizophreniaDanielle M Beaudette, James M Gold, James Waltz, et al.
Nature Reviews. Disease Primers|August 22, 2020
Comorbid depression in medical diseasesStefan M Gold, Ole Köhler-Forsberg, Rona Moss-Morris, et al.
Cannabis (Albuquerque, N.M.)|March 19, 2026
Clinical Experience and Student Support for Medical Cannabis Use: A Secondary AnalysisAndrew W Tong, Chloe J DuBoux, Rebecca H Seuferer, et al.
Neuropsychology|March 27, 2013
The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophreniaMelissa K Johnson, Robert P McMahon, Benjamin M Robinson, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Canadian Respiratory Journal|July 21, 2000
Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthmaL P Boulet, R L Cowie, R D Negro, et al.
Pageof 128

Showing results (771-780 of 1,272) with videos related to

Sort By:
Pageof 128
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2023
The MoXFo initiative - study design: Considerations related to study design and methodology in exercise research for people with multiple sclerosisUlrik Dalgas, Morten Riemenschneider, Stefan M Gold, et al.
Nature Communications|May 8, 2020
Cryo-electron microscopy reveals two distinct type IV pili assembled by the same bacteriumAlexander Neuhaus, Muniyandi Selvaraj, Ralf Salzer, et al.
Neuropsychologia|July 11, 2015
Cortical contributions to impaired contour integration in schizophreniaSteven M Silverstein, Michael P Harms, Cameron S Carter, et al.
Journal of Neuroimmunology|October 12, 2016
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosisSven Briken, Sina Cathérine Rosenkranz, Oliver Keminer, et al.
The Journal of Nervous and Mental Disease|December 14, 2020
Predicting Attention-Shaping Response in People With SchizophreniaDanielle M Beaudette, James M Gold, James Waltz, et al.
Nature Reviews. Disease Primers|August 22, 2020
Comorbid depression in medical diseasesStefan M Gold, Ole Köhler-Forsberg, Rona Moss-Morris, et al.
Cannabis (Albuquerque, N.M.)|March 19, 2026
Clinical Experience and Student Support for Medical Cannabis Use: A Secondary AnalysisAndrew W Tong, Chloe J DuBoux, Rebecca H Seuferer, et al.
Neuropsychology|March 27, 2013
The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophreniaMelissa K Johnson, Robert P McMahon, Benjamin M Robinson, et al.
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Canadian Respiratory Journal|July 21, 2000
Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthmaL P Boulet, R L Cowie, R D Negro, et al.
Pageof 128